Nature Communications · 2023 · 14 citations · 62 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeurodegenerationStructural BiologyAmyloid FormationNeurodegenerative DiseasesNeurodegenerative DisordersProtein AggregationProtein MisfoldingTau PathologyAmyloid-like AssemblyStructural DivergenceTau AggregationTau FibrillizationTau IsoformsTau Protein AggregationTau Protein IsoformsTau Seeding
Tau protein fibrillization is implicated in the pathogenesis of several neurodegenerative diseases collectively known as Tauopathies. For decades, investigating Tau fibrillization in vitro has required the addition of polyanions or other co-factors to induce its misfolding and aggregation, with heparin being the most commonly used. However, heparin-induced Tau fibrils exhibit high morphological heterogeneity and a striking structural divergence from Tau fibrils isolated from Tauopathies patients' brains at ultra- and macro-structural levels. To address these limitations, we developed a quick, cheap, and effective method for producing completely co-factor-free fibrils from all full-length Tau isoforms and mixtures thereof. We show that Tau fibrils generated using this ClearTau method - ClearTau fibrils - exhibit amyloid-like features, possess seeding activity in biosensor cells and hiPSC-derived neurons, retain RNA-binding capacity, and have morphological properties and structures more reminiscent of the properties of the brain-derived Tau fibrils. We present the proof-of-concept implementation of the ClearTau platform for screening Tau aggregation-modifying compounds. We demonstrate that these advances open opportunities to investigate the pathophysiology of disease-relevant Tau aggregates and will facilitate the development of Tau pathology-targeting and modifying therapies and PET tracers that can distinguish between different Tauopathies.
62
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani, John L. Rubinstein, David J. Fleet et al. · Nature Methods · 2017 · 10.7K citations
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Jasenko Zivanov, Takanori Nakane, Björn Forsberg et al. · eLife · 2018 · 5.4K citations · Full text
Life Sciences, Bioinformatics, High-performance Computing +14